Pictet Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Buy |
3,722,732
+87,152
| +2% | +$566K | 0.02% | 465 |
|
|
2025
Q1 | $28.8M | Buy |
3,635,580
+145,516
| +4% | +$1.15M | 0.03% | 411 |
|
|
2024
Q4 | $44.2M | Buy |
3,490,064
+507,398
| +17% | +$6.43M | 0.05% | 325 |
|
|
2024
Q3 | $41.5M | Buy |
2,982,666
+131,092
| +5% | +$1.83M | 0.05% | 331 |
|
|
2024
Q2 | $39.3M | Buy |
2,851,574
+476,437
| +20% | +$6.57M | 0.05% | 325 |
|
|
2024
Q1 | $39.2M | Sell |
2,375,137
-196,431
| -8% | -$3.25M | 0.04% | 359 |
|
|
2023
Q4 | $37.5M | Buy |
2,571,568
+1,971,529
| +329% | +$28.8M | 0.04% | 356 |
|
|
2023
Q3 | $7.36M | Buy |
+600,039
| New | +$7.36M | 0.01% | 681 |
|